J. Cardiol.2016 227 239.Bhattacharya S. Granger C. B. Craig D. Haynes C. Bain J. Stevens R. D. Hauser E. R. Newgard C. B. Kraus W. E. Newby L. K. Shah S. H. Atherosclerosis 2014 232 191-196.Feng Q. Liu Z. Zhong S. Li R. Xia H. Jie Z. Wen B. Chen X. Yan W. Fan Y. Guo Z. Meng N. Chen J. Yu X. Zhang Z. Kristiansen K. Wang J. Xu X.

2008 9 163.Vazquez-Baeza Y. Pirrung M. Gonzalez A. Knight R.GigaScience 2013 2 16.Wang M. Carver J. J. Phelan V. V. Sanchez L. M. Garg N. Peng Y. Nguyen D. D. Watrous J. Kapono C. A. Luzzatto-Knaan T. Porto C. Bouslimani A. Melnik A. V. Meehan M. J. Liu W. T. Crusemann M. Boudreau P. D. Esquenazi E. Sandoval-Calderon M. Kersten R. D. et al.

Song S. J. Metcalf J. L. Hyde E. R. Lladser M. Dorrestein P. C. Knight R. mSystems Online 2017 2.Pawlowsky-Glahn V. Egozcue J. J. Tolosana-Delgado R. In Proceedings of the 4th International Workshop on Compositional Data Analysis CoDawork Girona Spain 2011.Breitling R. Bakker B. Barrett M. Decuypere S. Dujardin J.-C.

2013 8 17-32.Bouslimani A. Porto C. Rath C. M. Wang M. Guo Y.Gonzalez A. Berg-Lyon D. Ackermann G. Moeller Christensen G. J. Nakatsuji T. Zhang L. Borkowski A. W. Meehan M. J. Dorrestein K. Gallo R. L. Bandeira N. Knight R. Alexandrov T. Dorrestein P. C. Proc.

A. Jr. Martins-Pinge M. C. Yamada-Ogatta S. F. Pinge-Filho P.Mediators Inflammation 2014 2014 1.Freire-de-Lima C. G. Nascimento D. O. Soares M. B. P. Bozza P. T. Castro-Faria-Neto H. C. de Mello F. G. DosReis G. A. Lopes M. F. Nature 2000 403 199-203.Borges M. M. Kloetzel J. K. Andrade H. F. Jr. Tadokoro C. E. Pinge-Filho P. Abrahamsohn I. Immunol.

Disease is thought to result from a combination of elevated pro-inflammatory cytokine release CD8 T cell- mediated cytotoxicity and reduced regulatory immune mechanisms leading to tissue damage.Parasite strain dose route of infection host immune status and host geneticasymptomatic so current treatment guidelines recommend treating all seropositive patients aged 50 and under even though the standard-of-care drug benznidazole causes significant adverse effects.There is thus an urgent need for a better understanding of Chagas disease pathogenesis and for the identification of markers of infection outcome.Fatal cases of Chagas disease often display a characteristic apical aneurysm at the bottom of the heart upon autopsy.We therefore sought to investigate the spatial relationship between parasite and host focusing on the small molecule interplay involved in parasite distribution and outcome of infection by applying untargeted liquid chromatography-tandem mass spectrometry LCMSMS analysis to sequential transverse heart sections in a mouse model of Chagas disease.

2015 65 1509-1520.Ganna A. Salihovic S. Sundstrom J. Broeckling C. D. Hedman A. K. Magnusson P. K. Pedersen N. L. Larsson A. Siegbahn A. Zilmer M. Prenni J. Arnlov J. Lind L. Fall T. Ingelsson E. PLoS Genet.

Oswaldo Cruz2017 112 224-235.Borges D. C. Araujo N. M. Cardoso C. R. Lazo Chica J. E.Immunology 2013 138 145-156.Dias G. B. Gruendling A. P. Araujo S. M. Gomes M. L. Toledo M. J. Exp.

The parasite burden was predominantly in the base top of the heart under fatal infection conditions ab whereas low dose infection with strain CL acute stage presented with a more balanced parasite distribution.

A multivariate response linear model accounting for the sample dependence with respect to the sampling site was performed directly on the balances using the following equation testing for the effects of parasite burden parasite dosage and sampling site along the heart and outcome.y  b0  b1xburden  b2xposition  b3xdose  b4xoutcomewhere y is the metabolite composition b0-b4 are the estimated regression coefficients xburden is the measured end point cardiac parasite burden xposition is the section position in the heart xdose is the amount of parasite injected at time 0 and xoutcome is the mouse survival outcome.Data Availability.

